Establishing the Generic Structure Potential of Bidayuh Bau-Jagoi Oral Folk Narratives, Dondan
Issues in Language Studies · 2019
DOI: 10.33736/ils.1611.2018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Issues in Language Studies, 2019. Verfasst von Yvonne Michelle Campbell und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
This study aimed to establish the genre status of the Bidayuh oral folk narrative, known as dondan, with a focus on the Bau-Jagoi Bidayuh group. In order to analyse the genre status of the dondan, the Generic Structure Potential (GSP) is used. The analyses revealed that the dondan has a similar GSP to English Fairy Tales but differs in terms of one of the elements, the Placement, which is an obligatory element in the dondan. The study also revealed that the Semantic Attributes which realises these GSP elements are more culturally based. Although the GSP of the dondan is similar to English Fairy Tales, it is the optional elements that reflect the culturally related elements of the dondan especially the communicative purpose to educate and disseminate cultural knowledge. Future work on oral folk narrative should include in-depth analysis of lexicogrammatical items.
Zitieren
APA
Campbell, Y. M., Ghazali, K., & Sahuri, S. S. S. (2019). Establishing the Generic Structure Potential of Bidayuh Bau-Jagoi Oral Folk Narratives, Dondan. Issues in Language Studies. https://doi.org/10.33736/ils.1611.2018
Vancouver
Campbell YM, Ghazali K, Sahuri SSS. Establishing the Generic Structure Potential of Bidayuh Bau-Jagoi Oral Folk Narratives, Dondan. Issues in Language Studies. 2019. doi:10.33736/ils.1611.2018
BibTeX
@article{Campbell2019,
author = {Campbell, Yvonne Michelle and Ghazali, Kamila and Sahuri, Sakina Sahuri Suffian},
title = {Establishing the Generic Structure Potential of Bidayuh Bau-Jagoi Oral Folk Narratives, Dondan},
journal = {Issues in Language Studies},
year = {2019},
doi = {10.33736/ils.1611.2018}
}
EUVIMED